等待開盤 09-11 09:30:00 美东时间
-0.010
-0.53%
(来源:医趋势) 近期,艾伯维血液肿瘤领域再迎重磅利好:其CD3/CD20双特异性抗体艾可瑞妥单抗(Epcoritamab)被国家药审中心纳入优先审评,适应症...
09-08 14:26
Heritage Global Partners ("HGP"), a subsidiary of Heritage Global Inc. (NASDAQ:HGBL) and a worldwide leader in asset advisory and auction services, has been appointed by the U.S. Bankruptcy Court for the District of
08-21 02:12
Companies Reporting Before The Bell • GoHealth (NASDAQ:GOCO) is estimated to re...
08-07 16:33
The EU patent allowance strengthens the prior patent allowance for LP-284 in the US, Japan India and Mexico.LP-284 has the potential to address B-cell lymphomas and other B-cell driven malignancies addressing a $4+
07-21 20:21
Heritage Glb (NASDAQ:HGBL) reported quarterly earnings of $0.03 per share which missed the analyst consensus estimate of $0.04 by 25 percent. This is a 40 percent decrease over earnings of $0.05 per share from the same
05-09 04:14
Companies Reporting Before The Bell • Sempra (NYSE:SRE) is likely to report qua...
05-08 16:33
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1107588488073326592.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• HC Wainwright & Co.:维持ProQR Therapeutics(PRQR)"买入"评级,目标价从10美元升至12美元</p> <p>• Oppenheimer:上调内克塔治疗(NKTR)评级至"跑
03-17 10:10
Heritage Global (($HGBL)) has held its Q4 earnings call. Read on for the main h...
03-15 08:21
Heritage Global ( ($HGBL) ) has provided an update. Heritage Global, Inc.’s Com...
01-04 05:31
Craig-Hallum analyst George Sutton maintained a Buy rating on Heritage Global (...
2024-10-30 21:15